Use of trifluoromethylphenyl-tetrahydropyridines for the preparation of pharmaceutical compositions useful for the treatment of anxiety and anxio-depressive disorders
CA 2003289 C · Owner: Sanofi-Aventis · Inventors: Simiand, Jacques; Soubrie, Philippe; Le Fur, Gerard
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the use of trifluoromethylphenyltetrahydropyridine derivatives of formula I. (see formula I) wherein Alk represents a straight or branched (C1-C4)alkylene chain and R is selected from the group consisting of cyano acetyl, (C3-C7)cycloalkyl, pyridyl, 1-oxide-pyridyl and naphthyl or of a pharamaceutically acceptable salt thereof, for the preparation of pharmaceutical compositions useful for the treatment of anxiety and anxio-depressive disorders. The invention also relates to the pharmaceutical compositions themselves.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 17, 1989 and granted July 18, 2000. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 17, 2009.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 17, 2011.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.